Found 23 matching trials
A Study to Assess Safety/Tolerability, pk, Effects on Histology, Clinical Parameters of Givinostat in Children With DMD
PHASE1The primary objective of Parts 1 and 2 of the study were to establish the h...
Location
Azienda Ospedaliera Universitaria Policlinico G. Martino
phII Study of an HDAC Inhibitor in Very High-risk Relapsed/Refractory Hodgkin's Lymphoma Patients
PHASE1PRIMARY OBJECTIVE
\- To evaluate the efficacy (according to the Internatio...
Location
Istituto Nazionale per lo studio e la cura dei Tumori
A Two-part Study to Assess the Safety and Preliminary Efficacy of Givinostat in Patients With Polycythemia Vera
PHASE1This is a two-part, multicenter, open label, non-randomized, phase Ib/II st...
Location
CHU Amiens - Hôpital Sud
Phase II Study of GIVINOSTAT (ITF2357) in Combination With Hydroxyurea in Polycythemia Vera
PHASE2The primary objective of the study was to evaluate the efficacy of Givinost...
Location
Azienda Ospedaliero-Universitaria Policlinico Consorziale di Bari
Phase II Clinical Trial of ITF2357 In Patients With Relapsed/Refractory Multiple Myeloma
PHASE2Primary objective:
To assess the safety of ITF 2357 administered once week...
Location
Presidio Ospedaliero R. Binaghi
Pharmacokinetics, Safety and Tolerability of ITF2357 in Participants With Chronic Hepatic Impairment and With Normal Hepatic Function
PHASE1This was a multicentric, open-label, non-randomized study to evaluate the p...
Location
MC COMAC Medical Ltd
The Efficacy and Safety of ITF2357 in AIS
PHASE2Autoinflammatory syndromes (AIS) are a group of disorders characterized by ...
Location
Radboud University Medical Centre Nijmegen
Open Label, Multicentre Trial to Assess Safety and Efficacy of ITF2357 in Active Systemic Juvenile Idiopathic Arthritis
PHASE2This study has the following objectives:
Primary objective:
\- To determi...
Location
Clinica Institute Fundeni.Pediatric Clinic 258 Sos. Fundeni,
Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera
PHASE3The goal of this clinical trial is to compare the efficacy and safety of gi...
Location
University of Alabama at Birmingham
Pharmacokinetics and Safety of Givinostat in DMD Patients Ages From at Least 2 Years to Less Then 6 Years Old
PHASE2This is a Phase 2 Open-label (Core Phase Plus Extension Phase) With 2 Cohor...
Location
Queen Fabiola Children's University Hospital HUDERF